Formulation development: which is the direction?

We are in the era of controlled release formulations, but new emerging technologies are coming, such as fixed dose combinations or those with dual release profile

Envi committee final opinion on the SPC manufacturing waiver makes genericists...

The ENVI Committee’s adoption of the Compromise Amendments on the SPC manufacturing waiver proposed regulation make genericists happy and originator disappointed.

Glabal Report

Job market in Life Science sector

A sample of Italian workers have been involved in the research "Talents in the Life Science 2018" of Kelly Services, according to which about two thirds (67%) of the respondents work with contractual forms different from the permanent one

Medical devices in 2030

Shift the focus from cost to value. An analisys of medical device markets and industry direction of next years, till 2030.



Blockchain technology in the pharmaceutical logistics industry

The potential of blockchain technology in the pharmaceutical logistics industry is significant; however, the transition to the effective adoption of these new solutions will require further technological development and the willingness to collaborate on the part of all the actors involved

Looking for philosopher’s stone

Next generation biotech could allow 200 years to live in the coming years. Based on Kris Verburgh, medical doctor interested in preventative medicine and aging and author of The Longevity Code "In the near future, we will see a new biotech age unfolding, in which our health, bodies and lifespan will drastically change"

Door-to-door distribution channel for supplements market

The direct door-to-door selling channel for supplements seems to grow. This data arrived from the Italian Integrators - AIIPA (New Line Market Research data) and AVEDISCO.

Innovation in packaging

A complete range of packaging services for all pharmaceutical forms, with reliability guaranteed by over...

Viela Bio, a new biotech company of the AstraZeneca’s galaxy

Viela Bio is a new, independent biotech company born from MedImmune - AstraZeneca’s global biologics research...

Pre-seed investments in Israel for Merck

ExploreBio is the new pre-seed-investment vehicle targeted at funding biotech early-stage companies and providing also management...